Abstract
To the Editor: The editorial by Laszlo and Lucas in the October 15 issue,1 along with a recent review by Seigel and Longo,2 shows that attention is being paid to the side effects of nausea and emesis as potentially limiting factors in some forms of chemotherapy. New antiemetic agents such as tetrahydrocannabinol3 and metoclopramide4 may prove useful in controlling these side effects after chemotherapy. Comparatively little is known, however, about emetic side effects that occur before a given treatment — anticipatory nausea and vomiting. Anticipatory side effects have been noted in case reports5; to our knowledge, the prevalence of . . .